NewsRSS2 days ago
ATTR-CM is a rare heart disease caused by abnormal protein buildup, but many patients also experience serious stomach and digestive problems that doctors don't always talk about. These gastrointestinal issues—like difficulty swallowing, nausea, and poor nutrient absorption—can be just as challenging as the heart symptoms and significantly impact quality of life. The article highlights that patients need better awareness and support for managing these hidden digestive complications alongside their heart treatment.
WHY IT MATTERSATTR-CM patients often suffer from overlooked gastrointestinal complications that can worsen malnutrition and quality of life, yet these symptoms receive less medical attention than cardiac manifestations—understanding this connection helps patients advocate for comprehensive care.
AdvocacyRSS2 days ago
A person with a muscular dystrophy explains how using a wheelchair has improved their quality of life and ability to participate in daily activities. Rather than viewing the wheelchair as a symbol of disability, they see it as a tool that gives them more independence and function. The article challenges common misconceptions about wheelchairs and disability.
WHY IT MATTERSThis perspective piece helps patients with muscular dystrophy and other mobility conditions understand that mobility aids like wheelchairs can expand independence rather than limit it, which may help reduce stigma and encourage earlier adoption of helpful devices.
NewsRSS2 days ago
A patient with Superior Mesenteric Artery Syndrome (SMAS) who had surgery is experiencing low iron levels (low ferritin), which is causing severe fatigue, brain fog, restless legs at night, and poor sleep. The article discusses how iron deficiency after SMAS surgery can make recovery harder and affect quality of life.
WHY IT MATTERSPatients recovering from SMAS surgery need to know that low ferritin levels are a treatable complication that directly causes the exhaustion and cognitive problems they may be experiencing post-operatively.
ResearchRSS2 days ago
A study of 34 patients in Hong Kong found that Evrysdi (a medicine taken by mouth) helped children and adults with spinal muscular atrophy (SMA) move better and feel better in their daily lives. Patients who had never taken SMA medicine before saw the biggest improvements. The good results lasted for up to three years.
WHY IT MATTERSThis real-world evidence from Asian patients shows Evrysdi works well outside of clinical trials, which may help doctors decide if it's the right treatment for SMA patients in your region.
ResearchPUBMEDApr 17
Researchers in Saudi Arabia studied how different factors affect the stress and well-being of parents who have children with three rare genetic diseases: cystic fibrosis, congenital adrenal hyperplasia, and Duchenne muscular dystrophy. They surveyed 107 parents and found that things like whether parents work, family income, and cultural factors all play a role in how well parents cope with having a sick child. Understanding these factors can help doctors and support services better help families dealing with rare diseases.
WHY IT MATTERSIf you're a parent of a child with CF, CAH, or DMD, this research identifies specific factors affecting your quality of life—such as employment status and family support—that healthcare providers can now address to improve your family's well-being.
Clinical trialUNITERAREApr 9
Researchers are testing a new medicine called difelikefalin to see if it's safe and works well for teenagers on kidney dialysis who have severe itching. Itching is a common problem for dialysis patients that can really affect their quality of life. This study will check whether the medicine helps reduce itching and what side effects it might cause.
WHY IT MATTERSThis is the first trial testing difelikefalin specifically in adolescents on hemodialysis with moderate-to-severe pruritus — a condition that significantly impacts quality of life but has limited treatment options for younger patients.
ResearchPUBMEDMar 26
A study in South Korea looked at how caring for someone with a rare genetic disease affects the caregiver's life and stress levels. Researchers surveyed 159 caregivers and found that caring for these patients creates real challenges that hurt caregivers' quality of life. The study examined what factors—like the patient's condition, available treatments, and genetic counseling—make caregiving easier or harder.
WHY IT MATTERSThis research identifies specific factors that increase caregiver burden in rare genetic diseases, which could help healthcare systems in South Korea and elsewhere design better support programs and counseling services for families managing these conditions.